+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells



Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells



Journal of Biological Chemistry 277(3): 2073-2080



We previously reported that apicidin arrested human cancer cell growth through selective induction of p21(WAF1/Cip1). In this study, the apoptotic potential of apicidin and its mechanism in HL60 cells was investigated. Treatment of HL60 cells with apicidin caused a decrease in viable cell number in a dose-dependent manner and an increase in DNA fragmentation, nuclear morphological change, and apoptotic body formation, concomitant with progressive accumulation of hyperacetylated histone H4. In addition, apicidin converted the procaspase-3 form to catalytically active effector protease, resulting in subsequent cleavages of poly(ADP-ribose) polymerase and p21(WAF1/Cip1). Incubation of HL60 cells with z-DEVD-fmk, a caspase-3 inhibitor, almost completely abrogated apicidin-induced activation of caspase-3, DNA fragmentation, and cleavages of poly(ADP-ribose) polymerase and p21(WAF1/Cip1). Moreover, these effects were preceded by an increase in translocation of Bax into the mitochondria, resulting in the release of cytochrome c and cleavage of procaspase-9. The addition of cycloheximide greatly inhibited activation of caspase-3 by apicidin by interfering with cleavage of procaspase-3 and DNA fragmentation, suggesting that apicidin-induced apoptosis was dependent on de novo protein synthesis. Consistent with these results, apicidin transiently increased the expressions of both Fas and Fas ligand. Preincubation with NOK-1 monoclonal antibody, which prevents the Fas-Fas ligand interaction and is inhibitory to Fas signaling, interfered with apicidin-induced translocation of Bax, cytochrome c release, cleavage of procaspase-3, and DNA fragmentation. Taken together, the results suggest that apicidin might induce apoptosis through selective induction of Fas/Fas ligand, resulting in the release of cytochrome c from the mitochondria to the cytosol and subsequent activation of caspase-9 and caspase-3.

(PDF emailed within 0-6 h: $19.90)

Accession: 003648738

Download citation: RISBibTeXText

PMID: 11698395

DOI: 10.1074/jbc.m106699200


Related references

Apicidin, a histone deacetylase inhibitor, induces apoptosis and PDCD4 expression in human T-cell leukemia cells. Blood 102(11): 596a, November 16, 2003

Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. Clinical Cancer Research 9(13): 5018-5027, 2003

Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells. Oncogene 27(10): 1376-1386, 2007

The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells. Blood 111(10): 5093-5100, 2008

Apicidin, a histone deacetylase inhibitor, potentiates STI571-induced apoptosis of Bcr-Abl-expressing human leukemia cells through Bcr-Abl downregulation and enhanced activation of mitochondria-dependent caspase cascade. Experimental Hematology (New York) 31(7 Supplement 1): 235, 2003

The new low-toxic histone deacetylase inhibitor S-2 induces apoptosis in various acute myeloid leukemia cells. 2011

Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells. Cancer Research 64(7): 2580-2589, 2004

The Histone Deacetylase Inhibitor BML-210 Influences Gene and Protein Expression in Human Promyelocytic Leukemia NB4 Cells via Epigenetic Reprogramming. International Journal of Molecular Sciences 16(8): 18252-18269, 2016

Histone deacetylase inhibitor apicidin induces cyclin E expression through Sp1 sites. Biochemical and Biophysical Research Communications 342(4): 1168-1173, 2006

Apicidin, a histone deacetylase inhibitor, induces differentiation of HL-60 cells. Cancer Letters 189(2): 197-206, 2002

Apicidin, a histone deacetylase inhibitor, induces differentiation of HL-60 cells. Cancer Letters 189(2): 197-206, January 28, 2003

Histone Deacetylase Inhibitor M344 Inhibits Cell Proliferation and Induces Apoptosis in Human THP-1 Leukemia Cells. American Journal of Biomedical Sciences 1(4): 352-363, 2010

Induction of apoptosis by apicidin, a histone deacetylase inhibitor, through activation of mitochondrial-dependent caspase cascade in human Bcr-Abl-expressing K562 cells. Proceedings of the American Association for Cancer Research Annual Meeting 44: 723, 2003

Epigenetic and molecular mechanisms underlying the antileukemic activity of the histone deacetylase inhibitor belinostat in human acute promyelocytic leukemia cells. Anti-Cancer Drugs 25(8): 938-949, 2015

Role of PKC epsilon in Gelsolin expression by histone deacetylase inhibitor apicidin in human cervix cancer cells. 2007